Please login to the form below

Not currently logged in

psoriatic arthritis

This page shows the latest psoriatic arthritis news and features for those working in and with pharma, biotech and healthcare.

Novartis gains label boost for Cosentyx

Novartis gains label boost for Cosentyx

Novartis' inflammation therapy blockbuster Cosentyx has added a new dosing flexibility in Europe for psoriatic arthritis patients. ... The lack of long-term efficacy for psoriatic arthritis treatments causes patients to move onto other options to keep on

Latest news

More from news
Approximately 13 fully matching, plus 112 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    Elsewhere, Celgene has seen large growth in 2017 (46%) - driven by sales of Otezla, the first oral small molecule to be approved for psoriasis and psoriatic arthritis. ... Similarly, Novartis has enjoyed 31.7% growth thanks to another psoriasis/psoriatic

  • Deal Watch December 2016 Deal Watch December 2016

    510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small

  • Taking a strategic approach Taking a strategic approach

    Just last month it was a 'patient access scheme' that brought Stelara (ustekinumab) NICE approval in psoriatic arthritis after the company agreed to provide the 90 mg dose (two vials) of

  • Pharma deals during July 2014 Pharma deals during July 2014

    Cimzia, a pegylated antibody fragment that blocks tumour necrosis factor alpha, is currently indicated for several disorders including Crohn's disease, rheumatoid arthritis and psoriatic arthritis.

  • An eye towards the biobetter in South Korea An eye towards the biobetter in South Korea

    Emerging area. Marketed in 2007. RA = rheumatoid arthritis; AS = ankylosing spondylitis; CD = Crohn's disease; PA = psoriatic arthritis; PS = psoriasis;.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Inflammatory Diseases Market is Set to Experience Revolutionary Growth by 2027

    Psoriasis. Inflammatory Bowel Disease. Bone disease. Rheumatoid Arthritis. Osteoarthritis. Others. Based on type of drug class, global inflammatory diseases market can be segmented into following. ... Psoriasis is systemic inflammation that causes red

  • Millefeuille

    Millefeuille. This story of hope charts Élodie’ s physical and mental struggles with psoriasis and psoriatic arthritis. ... For more information please visit Millefeuille. This story of hope charts Élodie’ s

  • Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

    Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis. Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this ... In this month’ s column we discuss how

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...